{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:31:56Z","timestamp":1786120316775,"version":"build-2736575974"},"reference-count":47,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1097\/mop.0b013e32834cd67a","type":"journal-article","created":{"date-parts":[[2011,10,4]],"date-time":"2011-10-04T19:52:52Z","timestamp":1317757972000},"page":"659-666","source":"Crossref","is-referenced-by-count":29,"title":["Gene therapy for primary immunodeficiency"],"prefix":"10.1097","volume":"23","author":[{"given":"Claire","family":"Booth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. Bobby","family":"Gaspar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian J.","family":"Thrasher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-16-20210206","first-page":"602","article-title":"Transplantation of hematopoietic stem cells and long-term survival for primary immunodeficiencies in Europe: entering a new century, do we do better J Allergy Clin I","volume":"126","author":"Gennery","year":"2010","journal-title":"mmunol"},{"key":"R2-16-20210206","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1136\/adc.2006.108787","article-title":"Update on clinical gene therapy in childhood.","volume":"92","author":"Qasim","year":"2007","journal-title":"Arch Dis Child"},{"key":"R3-16-20210206","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1172\/JCI35798","article-title":"Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients.","volume":"118","author":"Howe","year":"2008","journal-title":"J Clin Invest"},{"key":"R4-16-20210206","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.1172\/JCI35700","article-title":"Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1.","volume":"118","author":"Hacein-Bey-Abina","year":"2008","journal-title":"J Clin Invest"},{"key":"R5-16-20210206","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1126\/science.288.5466.669","article-title":"Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease.","volume":"288","author":"Cavazzana-Calvo","year":"2000","journal-title":"Science"},{"key":"R6-16-20210206","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1056\/NEJMoa1000164","article-title":"Efficacy of gene therapy for X-linked severe combined immunodeficiency.","volume":"363","author":"Hacein-Bey-Abina","year":"2010","journal-title":"N Engl J Med"},{"key":"R7-16-20210206","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1016\/S0140-6736(04)17590-9","article-title":"Gene therapy of X-linked severe combined immunodeficiency by use of a pseudotyped gammaretroviral vector.","volume":"364","author":"Gaspar","year":"2004","journal-title":"Lancet"},{"key":"R8-16-20210206","doi-asserted-by":"crossref","first-page":"97ra79","DOI":"10.1126\/scitranslmed.3002715","article-title":"Long-term persistence of a polyclonal T cell repertoire after gene therapy for X-linked severe combined immunodeficiency.","volume":"3","author":"Gaspar","year":"2011","journal-title":"Sci Transl Med"},{"key":"R9-16-20210206","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1182\/blood-2006-11-058933","article-title":"Gene therapy improves immune function in preadolescents with X-linked severe combined immunodeficiency.","volume":"110","author":"Chinen","year":"2007","journal-title":"Blood"},{"key":"R10-16-20210206","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1056\/NEJMoa0805817","article-title":"Gene therapy for immunodeficiency due to adenosine deaminase deficiency.","volume":"360","author":"Aiuti","year":"2009","journal-title":"N Engl J Med"},{"key":"R11-16-20210206","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1126\/science.1070104","article-title":"Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning.","volume":"296","author":"Aiuti","year":"2002","journal-title":"Science"},{"key":"R12-16-20210206","doi-asserted-by":"crossref","first-page":"97ra80","DOI":"10.1126\/scitranslmed.3002716","article-title":"Hematopoietic stem cell gene therapy for adenosine deaminase-deficient severe combined immunodeficiency leads to long-term immunological recovery and metabolic correction.","volume":"3","author":"Gaspar","year":"2011","journal-title":"Sci Transl Med"},{"key":"R13-16-20210206","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.ymthe.2006.06.007","article-title":"Successful reconstitution of immunity in ADA-SCID by stem cell gene therapy following cessation of PEG-ADA and use of mild preconditioning.","volume":"14","author":"Gaspar","year":"2006","journal-title":"Mol Ther"},{"key":"R14-16-20210206","doi-asserted-by":"crossref","first-page":"12133","DOI":"10.1073\/pnas.94.22.12133","article-title":"Prolonged production of NADPH oxidase-corrected granulocytes after gene therapy of chronic granulomatous disease.","volume":"94","author":"Malech","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R16-16-20210206","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/nm.2088","article-title":"Genomic instability and myelodysplasia with monosomy 7 consequent to EVI1 activation after gene therapy for chronic granulomatous disease.","volume":"16","author":"Stein","year":"2010","journal-title":"Nat Med"},{"key":"R17-16-20210206","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/nm1393","article-title":"Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM6 or SETBP1.","volume":"12","author":"Ott","year":"2006","journal-title":"Nat Med"},{"key":"R18-16-20210206","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1182\/blood-2009-05-222760","article-title":"Retrovirus gene therapy for X-linked chronic granulomatous disease can achieve stable long-term correction of oxidase activity in peripheral blood neutrophils.","volume":"115","author":"Kang","year":"2010","journal-title":"Blood"},{"key":"R20-16-20210206","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1056\/NEJMoa1003548","article-title":"Stem-cell gene therapy for the Wiskott-Aldrich syndrome.","volume":"363","author":"Boztug","year":"2010","journal-title":"N Engl J Med"},{"key":"R21-16-20210206","doi-asserted-by":"crossref","first-page":"4255","DOI":"10.1182\/blood-2004-12-4837","article-title":"Failure of SCID-X1 gene therapy in older patients.","volume":"105","author":"Thrasher","year":"2005","journal-title":"Blood"},{"key":"R22-16-20210206","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1172\/JCI31659","article-title":"Vector integration is nonrandom and clustered and influences the fate of lymphopoiesis in SCID-X1 gene therapy.","volume":"117","author":"Deichmann","year":"2007","journal-title":"J Clin Invest"},{"key":"R23-16-20210206","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1038\/gt.2009.127","article-title":"Progress and prospects: gene therapy for inherited immunodeficiencies.","volume":"16","author":"Qasim","year":"2009","journal-title":"Gene Ther"},{"key":"R24-16-20210206","doi-asserted-by":"crossref","first-page":"12133","DOI":"10.1073\/pnas.94.22.12133","article-title":"Prolonged production of NADPH oxidase-corrected granulocytes after gene therapy of chronic granulomatous disease.","volume":"94","author":"Malech","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R25-16-20210206","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1159\/000072457","article-title":"Gene therapy for chronic granulomatous disease.","volume":"110","author":"Goebel","year":"2003","journal-title":"Acta Haematol"},{"key":"R26-16-20210206","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1182\/blood-2009-05-221606","article-title":"Restoration of net formation by gene therapy in CGD controls aspergillosis.","volume":"114","author":"Bianchi","year":"2009","journal-title":"Blood"},{"key":"R27-16-20210206","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/mt.2010.232","article-title":"Gene therapy of chronic granulomatous disease: the engraftment dilemma.","volume":"19","author":"Grez","year":"2011","journal-title":"Mol Ther"},{"key":"R29-16-20210206","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1182\/blood.V92.4.1131","article-title":"Ex vivo expansion of genetically marked rhesus peripheral blood progenitor cells results in diminished long-term repopulating ability.","volume":"92","author":"Tisdale","year":"1998","journal-title":"Blood"},{"key":"R30-16-20210206","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1038\/sj.leu.2401537","article-title":"Molecular control of cell cycle progression in primary human hematopoietic stem cells: methods to increase levels of retroviral-mediated transduction.","volume":"13","author":"Dao","year":"1999","journal-title":"Leukemia"},{"key":"R31-16-20210206","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/emmm.201000108","article-title":"Integration profile of retroviral vector in gene therapy treated patients is cell-specific according to gene expression and chromatin conformation of target cell.","volume":"3","author":"Biasco","year":"2011","journal-title":"EMBO Mol Med"},{"key":"R32-16-20210206","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/mt.2009.31","article-title":"Evidence for long-term efficacy and safety of gene therapy for Wiskott-Aldrich syndrome in preclinical models.","volume":"17","author":"Marangoni","year":"2009","journal-title":"Mol Ther"},{"key":"R33-16-20210206","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1038\/3233","article-title":"Thymic lymphoproliferative disease after successful correction of CD40 ligand deficiency by gene transfer in mice.","volume":"4","author":"Brown","year":"1998","journal-title":"Nat Med"},{"key":"R34-16-20210206","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1038\/gt.2010.144","article-title":"A tissue-specific, activation-inducible, lentiviral vector regulated by human CD40L proximal promoter sequences.","volume":"18","author":"Romero","year":"2011","journal-title":"Gene Ther"},{"key":"R35-16-20210206","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/gt.2010.7","article-title":"Lentiviral vectors incorporating a human elongation factor-1 alpha promoter for the treatment of canine leukocyte adhesion deficiency.","volume":"17","author":"Nelson","year":"2010","journal-title":"Gene Ther"},{"key":"R36-16-20210206","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1089\/hum.2010.130","article-title":"Gene therapy for canine leukocyte adhesion deficiency with lentiviral vectors using the murine stem cell virus and human phosphoglycerate kinase promoters.","volume":"22","author":"Hunter","year":"2011","journal-title":"Hum Gene Ther"},{"key":"R37-16-20210206","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/mt.2010.203","article-title":"Gene therapy of canine leukocyte adhesion deficiency using lentiviral vectors with human CD11b and CD18 promoters driving canine CD18 expression.","volume":"19","author":"Hunter","year":"2011","journal-title":"Mol Ther"},{"key":"R38-16-20210206","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/mt.2010.226","article-title":"Biochemical correction of X-CGD by a novel chimeric promoter regulating high levels of transgene expression in myeloid cells.","volume":"19","author":"Santilli","year":"2011","journal-title":"Mol Ther"},{"key":"R39-16-20210206","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1038\/leu.2010.140","article-title":"Correction of B-cell development in BTK-deficient mice using lentiviral vectors with codon-optimized human BTK.","volume":"24","author":"Ng","year":"2010","journal-title":"Leukemia"},{"key":"R40-16-20210206","doi-asserted-by":"crossref","first-page":"3942","DOI":"10.1182\/blood-2002-03-0782","article-title":"Gene therapy of RAG-2 mice: sustained correction of the immunodeficiency.","volume":"100","author":"Yates","year":"2002","journal-title":"Blood"},{"key":"R41-16-20210206","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1038\/leu.2011.106","article-title":"Correction of murine RAG1 deficiency by self-inactivating lentiviral vector-mediated gene transfer.","volume":"25","author":"Pike-Overzet","year":"2011","journal-title":"Leukemia"},{"key":"R42-16-20210206","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1038\/mt.2010.132","article-title":"A ubiquitous chromatin opening element (UCOE) confers resistance to DNA methylation-mediated silencing of lentiviral vectors.","volume":"18","author":"Zhang","year":"2010","journal-title":"Mol Ther"},{"key":"R43-16-20210206","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1182\/blood-2006-12-060814","article-title":"Lentiviral vectors containing an enhancer-less ubiquitously acting chromatin opening element (UCOE) provide highly reproducible and stable transgene expression in hematopoietic cells.","volume":"110","author":"Zhang","year":"2007","journal-title":"Blood"},{"key":"R44-16-20210206","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/nrg2985","article-title":"Ex vivo gene transfer and correction for cell-based therapies.","volume":"12","author":"Naldini","year":"2011","journal-title":"Nat Rev Genet"},{"key":"R45-16-20210206","doi-asserted-by":"crossref","first-page":"4609","DOI":"10.1128\/MCB.01652-07","article-title":"MicroRNA-126 regulates HOXA9 by binding to the homeobox.","volume":"28","author":"Shen","year":"2008","journal-title":"Mol Cell Biol"},{"key":"R46-16-20210206","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/j.jaci.2011.02.027","article-title":"Gene therapy for primary immunodeficiencies: looking ahead, toward gene correction.","volume":"127","author":"Pessach","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"R47-16-20210206","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1038\/mt.2008.118","article-title":"Stable and functional lymphoid reconstitution in artemis-deficient mice following lentiviral artemis gene transfer into hematopoietic stem cells.","volume":"16","author":"Benjelloun","year":"2008","journal-title":"Mol Ther"},{"key":"R48-16-20210206","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/sj.mt.6300353","article-title":"Restoration of human B-cell differentiation into NOD-SCID mice engrafted with gene-corrected CD34 cells isolated from artemis or RAG1-deficient patients.","volume":"16","author":"Lagresle-Peyrou","year":"2008","journal-title":"Mol Ther"},{"key":"R49-16-20210206","doi-asserted-by":"crossref","first-page":"16406","DOI":"10.1073\/pnas.0608130103","article-title":"Complete correction of murine artemis immunodeficiency by lentiviral vector-mediated gene transfer.","volume":"103","author":"Mostoslavsky","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R50-16-20210206","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1002\/jgm.1261","article-title":"Lentivirus gene therapy for purine nucleoside phosphorylase deficiency.","volume":"10","author":"Liao","year":"2008","journal-title":"J Gene Med"}],"container-title":["Current Opinion in Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MOP.0b013e32834cd67a","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T20:28:50Z","timestamp":1786048130000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00008480-201112000-00016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":47,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/mop.0b013e32834cd67a","relation":{},"ISSN":["1040-8703"],"issn-type":[{"value":"1040-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]}}}